Along with the significant growth of genetic testing over the past two decades has come a rise in test fraud schemes targeting Medicare beneficiaries. Now, the Trump administration is requesting ...

The FDA sent the warning letter after an inspection of Exactech’s Sarasota, Florida, facility in July. At the time of the inspection, Exactech had not yet received court approval to sell its assets ...

The full scope of the impact, including operational and financial effects, is not yet known. Stryker does not have a timeline for full restoration of its systems.

MiniMed, Medtronic’s diabetes tech spinoff, made its debut on the public markets Friday. The company started trading on the ...

Haag, who has worked at Medtronic for 20 years, will also serve on the leadership team for the neuroscience group.

Wood spent 20 years at J&J, culminating in a spell as company group chairman for the medtech business in Europe, the Middle East and Africa.

Expecting pivotal data this year, the company has raised a Series C round to support the launch of a noninvasive device ...

The robotics company, which has taken steps to preserve cash amid the latest change of course in the development of its ...

Medtronic on Tuesday priced a planned initial public offering for its MiniMed diabetes spinoff at up to $784 million. MiniMed ...

The research initiative is part of a broader focus on wearables at the Department of Health and Human Services.

Intuitive co-founder Fred Moll invested $2 million, supporting SS Innovations’ efforts to launch its robot in the U.S.

The White House has outlined the timeline for additional trade actions it plans to take as it seeks to reconstruct President Donald Trump’s far-reaching tariff regime following a Supreme Court ...